SSD8432/Ritonavir

SSD8432/Ritonavir · Jiangsu Simcere Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SSD8432/Ritonavir, covering 2022-05-24 to 2023-05-31. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 [Phase 1, Phase 2]